Open Beta
MetriLume

US marketsBNGO

SEC-sourced researchBeta

BNGO

Bionano Genomics, Inc.

Company comparison ↗

Data passport

CIK
0001411690
Exchange
Nasdaq
Business activity
Laboratory Analytical Instruments · SIC 3826
Financial inputs
6/6
Filing date
Nov 16, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 30,776,000.0000 USD; December 2025: 28,508,000.0000 USD30.8M USD0 USD0December 2024December 2025
BNGO · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202430,776,000.0000Mar 23, 2026
December 202528,508,000.0000Mar 23, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202528,508,000.0000-26,395,000.0000-16,345,000.000073,584,000.000029,160,000.0000Mar 23, 2026
December 202430,776,000.0000-112,017,000.0000-68,922,000.000076,670,000.000041,295,000.0000Mar 23, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

41/100
Profitability0
Growth43
Balance sheet60
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$28.51MJan 1, 2025 – Dec 31, 2025Mar 23, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$30.78MJan 1, 2024 – Dec 31, 2024Mar 23, 202610-K
Net incomeNetIncomeLoss-$26.4MJan 1, 2025 – Dec 31, 2025Mar 23, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$16.35MJan 1, 2025 – Dec 31, 2025Mar 23, 202610-K
Total assetsAssets$73.58MDec 31, 2025Mar 23, 202610-K
Total liabilitiesLiabilities$29.16MDec 31, 2025Mar 23, 202610-K

New filings

Explore methodology ↗